2022 Full Year Guidance and Strategic Outlook
Equipment & Consumables
Kerr Metrex DEXIS
INFECTION PREVENTION
Solid performance in Imaging & Restorative; offset by Infection Prevention
Revenue
Core Sales* -3.3%
Adjusted Operating
Profit Margin*
($m)
$246.1
$234.3
21.4%
20.7%
Sales
Adjusted Operating Margin
Q1 2021 Q1 2022
•
Core Sales Growth*
- Strong growth in Resto/Endo driven by robust sell-out
- Solid MSD growth in Imaging
- Infection Prevention declined vs. pandemic peak; Expect continued
weakness in Q2, followed by rebound in 2H
Profitability
- Strong expansion of operating margins in Imaging & Resto/Endo
- Overall margins negatively impacted by Infection Prevention (vs.
pandemic peak in prior year)
* Core sales growth and adjusted operating profit margin are non-GAAP financial measures. For a reconciliation to the most directly comparable GAAP measures, please see Appendix.
7
EnvistaView entire presentation